Subscribe To
Bullish news may push vertex pharmaceuticals above 52-week high
Vertex pharmaceuticals, Inc. (NASDAQ: VRTX) is positioned to make a new run at the 52-week high of $325...
March 28, 2023, 6:46 am
It's a mistake to ignore the growth potential of these 3 dividend stocks
Coca-Cola's well-diversified portfolio of beverages creates an evergreen play. Johnson & Johnson's mix of phar...
March 28, 2023, 5:10 am
Addex therapeutics to release full-year 2022 financial results and host conference call on march 30, 2023
Geneva, Switzerland, March 2 8 , 20 2 3 – Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharma...
March 28, 2023, 1:00 am
2 instruments stocks to watch from a challenging industry
The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD) and Waters (WAT) are gaining from strong life science, ...
March 27, 2023, 1:45 pm
Sanofi, regeneron shares pop on big news about copd treatment
Shares of Sanofi (NASDAQ: SNY) were up 10.20% the week ended March 24, while Regeneron pharmaceuticals ...
March 27, 2023, 1:26 pm
Here's why phathom pharmaceuticals, inc. (phat) is a great 'buy the bottom' stock now
Phathom pharmaceuticals, Inc. (PHAT) appears to have found support after losing some value lately, as i...
March 27, 2023, 11:26 am
Acumen pharmaceuticals, inc. (abos) q4 2022 earnings call transcript
Acumen pharmaceuticals, Inc. (NASDAQ:ABOS ) Q4 2022 Earnings Conference Call March 27, 2023 8:00 AM ET ...
March 27, 2023, 11:05 am
Codiak biosciences files for bankruptcy, looks to sell off assets
Codiak BioSciences Inc. CDAK, -4.56% said Monday that it has field for bankruptcy, and it looking to selloff of its assets to maximize the company's v...
March 27, 2023, 7:26 am
Aclaris therapeutics to participate in the h.c. wainwright autoimmune & inflammatory disease virtual conference
WAYNE, Pa., March 27, 2023 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage bio...
March 27, 2023, 7:00 am
Is viking therapeutics a smart buy on the dip?
Shares of Viking Therapeutics fell 25.2% during the week that ended March 24. Viking pharmaceuticals fe...
March 27, 2023, 5:47 am
Immupharma: us partner has submitted lupuzor phase ii/iii trial protocol
ImmuPharma PLC (AIM:IMM, OTC:IMMPF) has said its partner Avion pharmaceuticals has submitted the phase ...
March 27, 2023, 2:51 am
Bristol-myers squibb: growth story and valuation is convincing
Despite dealing with a pharmaceutical company, Bristol-Myers Squibb's performance during recessions was...
March 26, 2023, 4:50 am
Ligand pharmaceuticals: expanding royalty portfolio and strong drug pipeline
Ligand's strategy of providing development capital to high-quality assets with capable teams is paying off, as evidenced by the recent positive develo...
March 25, 2023, 10:30 am
Deciphera pharmaceuticals: in the middle of a major comeback (upgrade)
Last year, Deciphera pharmaceuticals, Inc. was almost destroyed by a trial failure. This year, Decipher...
March 25, 2023, 8:00 am
Nasdaq bear market: 2 growth stocks to buy that keep bucking the trend
The Nasdaq Composite index has been down for over a year now, but some of its components are soaring. Vertex p...
March 25, 2023, 5:41 am
Lightning round: occidental is warren buffett's favorite, it's not my favorite
Mad Money host Jim Cramer weighs in on all manner of stocks, including Barrick Gold, Occidental, Lumentum Holdings, Nordic American Tanker, Petrobras,...
March 24, 2023, 7:57 pm
Nike, ubs, mgc pharmaceuticals, nvidia, travelzoo top the analyst calls of the week
March 24, 2023, 4:31 pm
Insmed to present new clinical, pre-clinical, and real-world data in serious and rare lung diseases at the american thoracic society 2023 international conference
—Data from Retrospective Study Evaluating the Association Between Hospitalization Burden and Delay in Diagnosis of Nontuberculous Mycobacterial (NTM...
March 24, 2023, 4:22 pm
Pph fell as much as the market despite resilience
The US market is highly speculative right now, as it's bid up to levels comparable to before stresses in the banking system had been revealed by SVB F...
March 24, 2023, 3:49 pm
Impel pharmaceuticals inc. (impl) q4 2022 earnings call transcript
Impel pharmaceuticals Inc. (NASDAQ:IMPL ) Q4 2022 Earnings Conference Call March 24, 2023 8:30 AM ET Co...
March 24, 2023, 3:20 pm